CDK inhibitors (CKIs) regulate the G1 phase of the cell cycle by controlling the activity of cyclin-dependent kinases (CDKs). CKIs are divided into two families: INK4 proteins, which inhibit CDK4 and CDK6, and Cip/Kip proteins, which inhibit a broader range of CDKs, including those dependent on cyclin D, E, and A. INK4 proteins, such as p16, p15, p18, and p19, bind specifically to CDK4 and CDK6, while Cip/Kip proteins, including p21, p27, and p57, bind to both cyclins and CDKs. Recent studies have shown that Cip/Kip proteins can act as positive regulators of cyclin D-dependent kinases, challenging previous assumptions about their role in the G1/S transition. This dual role of Cip/Kip proteins helps explain the complex regulation of the cell cycle, including the functions of the retinoblastoma protein (Rb) and the INK4 proteins. The interplay between these regulators ensures proper progression through the G1 phase and entry into S phase. The study highlights the biochemical interactions between CKIs and cyclin D- and E-dependent kinases in cultured mammalian cells, emphasizing their cooperative role in governing the G1-to-S transition. Understanding these interactions is crucial for comprehending the mechanisms of cell cycle regulation and their implications in cancer. The research also discusses the roles of cyclin D-dependent kinases in phosphorylating Rb, which is essential for the activation of E2F family members and the initiation of DNA synthesis. The study provides insights into how the cell cycle is regulated by various CKIs and their interactions with cyclin-dependent kinases, contributing to a better understanding of cell cycle control and its relevance in cancer development.CDK inhibitors (CKIs) regulate the G1 phase of the cell cycle by controlling the activity of cyclin-dependent kinases (CDKs). CKIs are divided into two families: INK4 proteins, which inhibit CDK4 and CDK6, and Cip/Kip proteins, which inhibit a broader range of CDKs, including those dependent on cyclin D, E, and A. INK4 proteins, such as p16, p15, p18, and p19, bind specifically to CDK4 and CDK6, while Cip/Kip proteins, including p21, p27, and p57, bind to both cyclins and CDKs. Recent studies have shown that Cip/Kip proteins can act as positive regulators of cyclin D-dependent kinases, challenging previous assumptions about their role in the G1/S transition. This dual role of Cip/Kip proteins helps explain the complex regulation of the cell cycle, including the functions of the retinoblastoma protein (Rb) and the INK4 proteins. The interplay between these regulators ensures proper progression through the G1 phase and entry into S phase. The study highlights the biochemical interactions between CKIs and cyclin D- and E-dependent kinases in cultured mammalian cells, emphasizing their cooperative role in governing the G1-to-S transition. Understanding these interactions is crucial for comprehending the mechanisms of cell cycle regulation and their implications in cancer. The research also discusses the roles of cyclin D-dependent kinases in phosphorylating Rb, which is essential for the activation of E2F family members and the initiation of DNA synthesis. The study provides insights into how the cell cycle is regulated by various CKIs and their interactions with cyclin-dependent kinases, contributing to a better understanding of cell cycle control and its relevance in cancer development.